Part 2. Improvement criteria in drug trials with neurotic patients

1 February 1972

journal article
research article
Published by Cambridge University Press (CUP) in Psychological Medicine

Vol. 2 (1), 73-80
https://doi.org/10.1017/s0033291700045645

Abstract

Based on the available research evidence, several rating and self-rating methods are recommended which appear to be suitable for the measurement of changes in distress in drug trials with neurotic patients.

Keywords

This publication has 112 references indexed in Scilit:

The Temporal Stability of Self‐Ratings of Neurotic Symptoms
British Journal of Social and Clinical Psychology, 1970
Meprobamate- Benactyzine (Deprol) and Placebo in Two Depressed Outpatient Populations
Psychosomatics, 1969
Iprindole in Neurotic Depressed General Practice Patients: A Controlled Study
Psychosomatics, 1968
The evidence in favour of psychotherapy
Psychology and Psychotherapy: Theory, Research and Practice, 1967
A VARIABLE DOSE PHASE 3, HUMAN BIOASSAY OF NORTRIPTYLINE
The American Journal of the Medical Sciences, 1965
A Double-blind Study in a Group of Patients With Anxiety and Depression
Psychosomatics, 1965
A New Psychotropic Drug: Evaluation of Tybamate in the Treatment of Anxiety and Tension States
Psychosomatics, 1964
A Clinical, Double-Blind Comparison of Librium, Meprobamate and Phenobarbital
Psychosomatics, 1962
Benactyzine in Psychoneurosis
BMJ, 1956
RESERPINE IN THE TREATMENT OF ANXIOUS AND DEPRESSED PATIENTS
The Lancet, 1955

Cited by 52 articles